Pharmacogenetic considerations in the treatment of psychiatric disorders (Q37681573)

22 August 2017

1 reference

title

Pharmacogenetic considerations in the treatment of psychiatric disorders (English)

1 reference

ORCID Public Data File 2021

22 August 2017

1 reference

author name string

Falk W Lohoff

series ordinal

1

1 reference

PubMed ID

20102306

22 August 2017

Thomas N Ferraro

series ordinal

2

1 reference

PubMed ID

20102306

22 August 2017

language of work or name

English

0 references

publication date

1 February 2010

1 reference

Expert Opinion on Pharmacotherapy

22 August 2017

1 reference

22 August 2017

11

1 reference

22 August 2017

3

1 reference

22 August 2017

423-439

1 reference

A review on the impact of P-glycoprotein on the penetration of drugs into the brain. Focus on psychotropic drugs

22 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Role of pharmacogenetics of ATP-binding cassette transporters in the pharmacokinetics of drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

The functioning and well-being of patients with unrecognized anxiety disorders and major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Generalized anxiety disorder: prevalence, burden, and cost to society.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Pharmacogenomics and antidepressant drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

ABC drug transporter at the blood-brain barrier: effects on drug metabolism and drug response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Clinical applications of pharmacogenetics in psychiatry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Pharmacogenetics and pharmacogenomics: development, science, and translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Cytochrome P4502D6 (CYP2D6) gene locus heterogeneity: characterization of gene duplication events.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Molecular genetics of CYP2D6: clinical relevance with focus on psychotropic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Polymorphisms in the CYP 2D6 gene: association with plasma concentrations of fluoxetine and paroxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Venlafaxine serum levels and CYP2D6 genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

CYP2D6 polymorphism and clinical effect of the antidepressant venlafaxine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Regulation of drug metabolism in man by environmental factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

The influence of Serotonin Transporter Promoter Polymorphism (SERTPR) and other polymorphisms of the serotonin pathway on the efficacy of antidepressant treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Serotonin transporter polymorphism (5-HTTLPR) association with melancholic depression: a female specific effect?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Pharmacogenetic studies of antidepressant response: how far from the clinic?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Pharmacogenomics with antidepressants in the STAR*D study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Electroconvulsive shock decreases binding to 5-HT2 receptors in nonhuman primates: an in vivo positron emission tomography study with [18F]setoperone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

The cellular neurobiology of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Association of GRIK4 with outcome of antidepressant treatment in the STAR*D cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Analysis of association between the serotonin transporter and antidepressant response in a large clinical sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Association between a functional serotonin transporter promoter polymorphism and citalopram treatment in adult outpatients with major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Genetic markers of suicidal ideation emerging during citalopram treatment of major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Association between treatment-emergent suicidal ideation with citalopram and polymorphisms near cyclic adenosine monophosphate response element binding protein in the STAR*D study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

A genomewide association study points to multiple loci that predict antidepressant drug treatment outcome in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Pharmacogenetic studies in depression: a proposal for methodologic guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Measuring depression: comparison and integration of three scales in the GENDEP study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Genetic predictors of response to antidepressants in the GENDEP project

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Pharmacogenetics of antidepressant medication intolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Serotonin transporter polymorphisms and the occurrence of adverse events during treatment with selective serotonin reuptake inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Genetic and clinical predictors of sexual dysfunction in citalopram-treated depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Antidepressants and the risk of suicidal behaviors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Early evidence on the effects of regulators' suicidality warnings on SSRI prescriptions and suicide in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Association of a polymorphism near CREB1 with differential aversion processing in the insula of healthy participants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Abnormal glucose metabolism in patients treated with antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Metabolic drug interactions with newer antipsychotics: a comparative review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Metabolism of atypical antipsychotics: involvement of cytochrome p450 enzymes and relevance for drug-drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

The involvement of CYP1A2 and CYP3A4 in the metabolism of clozapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Six novel nonsynonymous CYP1A2 gene polymorphisms: catalytic activities of the naturally occurring variant enzymes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Functional significance of a C-->A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Treatment-resistance to clozapine in association with ultrarapid CYP1A2 activity and the C-->A polymorphism in intron 1 of the CYP1A2 gene: effect of grapefruit juice and low-dose fluvoxamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Nonresponse to clozapine and ultrarapid CYP1A2 activity: clinical data and analysis of CYP1A2 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Increased clozapine plasma concentrations and side effects induced by smoking cessation in 2 CYP1A2 genotyped patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Modern antipsychotic drugs: a critical overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Phenotype of schizophrenia: a review and formulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

A PET study of dopamine D2 and serotonin 5-HT2 receptor occupancy in patients with schizophrenia treated with therapeutic doses of ziprasidone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

The influence on the schizophrenic symptoms by the DRD2Ser/Cys311 and -141C Ins/Del polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Response to chlorpromazine treatment may be associated with polymorphisms of the DRD2 gene in Chinese schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

DRD2 promoter region variation as a predictor of sustained response to antipsychotic medication in first-episode schizophrenia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Proposed schizophrenia-related gene polymorphism: expression of the Ser9Gly mutant human dopamine D3 receptor with the Semliki Forest virus system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Role of dopamine D3 receptor (DRD3) and dopamine transporter (DAT) polymorphism in cognitive dysfunctions and therapeutic response to atypical antipsychotics in patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Pharmacogenetics of treatment in first-episode schizophrenia: D3 and 5-HT2C receptor polymorphisms separately associate with positive and negative symptom response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Meta-analysis of studies on genetic variation in 5-HT2A receptors and clozapine response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Evidence for an association between polymorphism in the serotonin-2A receptor variant (102T/C) and increment of N100 amplitude in schizophrenics treated with clozapine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Association of risperidone treatment response with a polymorphism in the 5-HT(2A) receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Serotonin subtype 2 receptor genes and clinical response to clozapine in schizophrenia patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Does antipsychotic polypharmacy increase the risk for metabolic syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Clozapine: weight gain in a pair of monozygotic twins concordant for schizophrenia and mild mental retardation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Clozapine-induced weight gain: a study in monozygotic twins and same-sex sib pairs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Weight gain associated with the -759C/T polymorphism of the 5HT2C receptor and olanzapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Clozapine-induced weight gain associated with the 5HT2C receptor -759C/T polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Polymorphisms of the 5-HT2C receptor and leptin genes are associated with antipsychotic drug-induced weight gain in Caucasian subjects with a first-episode psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

The 5-HT2C receptor and antipsychoticinduced weight gain - mechanisms and genetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Polymorphism of the promoter region of the serotonin 5-HT(2C) receptor gene and clozapine-induced weight gain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Association of antipsychotic drug-induced weight gain with a 5-HT2C receptor gene polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Genetics of antipsychotic treatment emergent weight gain in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Clinical implications of pharmacogenomics for tardive dyskinesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Association between the Ser9Gly polymorphism of the dopamine D3 receptor gene and tardive dyskinesia in Chinese schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Dopamine D3-receptor gene variant and susceptibility to tardive dyskinesia in schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Pharmacogenetics of tardive dyskinesia: combined analysis of 780 patients supports association with dopamine D3 receptor gene Ser9Gly polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Antipsychotic-induced tardive dyskinesia and the Ser9Gly polymorphism in the DRD3 gene: a meta analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Active monitoring of 12,760 clozapine recipients in the UK and Ireland. Beyond pharmacovigilance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

An association between clozapine-induced agranulocytosis in schizophrenics and HLA-DQB1*0201.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Further evidence of human leukocyte antigen-encoded susceptibility to clozapine-induced agranulocytosis independent of ancestry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

HLA-B38 and clozapine-induced agranulocytosis in Israeli Jewish schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Spectrum of effectiveness of valproate in neuropsychiatry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Psychotropic effects of antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

A history of the use of anticonvulsants as mood stabilizers in the last two decades of the 20th century.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

The relationship between the pharmacology of antiepileptic drugs and human gene variation: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Effects of genetic polymorphism of cytochrome P450 enzymes on the pharmacokinetics of benzodiazepines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Treatment of bipolar disorder: a systematic review of available data and clinical perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Factors associated with treatment success in lithium carbonate prophylaxis. Report of the Veterans Administration and National Institute of Mental Health collaborative study group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Outcomes on lithium treatment as a tool for genetic studies in affective disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Neural and developmental actions of lithium: a unifying hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

A molecular mechanism for the effect of lithium on development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Long-term response to lithium salts in bipolar illness is influenced by the glycogen synthase kinase 3-beta -50 T/C SNP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

A single nucleotide polymorphism in glycogen synthase kinase 3-beta promoter gene influences onset of illness in patients affected by bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Association study of the glycogen synthase kinase-3beta gene polymorphism with prophylactic lithium response in bipolar patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Response to lithium augmentation in depression is associated with the glycogen synthase kinase 3-beta -50T/C single nucleotide polymorphism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Pharmacogenetics and bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Pharmacogenetics of lithium prophylaxis in mood disorders: analysis of COMT, MAO-A, and Gbeta3 variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Dopamine receptor D2 and D4 genes, GABA(A) alpha-1 subunit genes and response to lithium prophylaxis in mood disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Excess of transmission of the G allele of the -1438A/G polymorphism of the 5-HT2A receptor gene in patients with schizophrenia responsive to antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

The pharmacogenetics of lithium response depends upon clinical co-morbidity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Association studies of the BDNF and the NTRK2 gene polymorphisms with prophylactic lithium response in bipolar patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Lithium response and genetic variation in the CREB family of genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Serotonin transporter linked promoter (polymorphism) in the serotonin transporter gene may be associated with antidepressant-induced mania in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

A possible association between the -116C/G single nucleotide polymorphism of the XBP1 gene and lithium prophylaxis in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Lithium response and Val66Met polymorphism of the brain-derived neurotrophic factor gene in Japanese patients with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Association study of the INPP1, 5HTT, BDNF, AP-2beta and GSK-3beta GENE variants and restrospectively scored response to lithium prophylaxis in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Prophylactic lithium response and polymorphism of the brain-derived neurotrophic factor gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Serotonin transporter gene associated with lithium prophylaxis in mood disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Further evidence for a possible association between serotonin transporter gene and lithium prophylaxis in mood disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Risk of serious cutaneous disorders after initiation of use of phenytoin, carbamazepine, or sodium valproate: a record linkage study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Medical genetics: a marker for Stevens-Johnson syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Association between HLA-B*1502 allele and antiepileptic drug-induced cutaneous reactions in Han Chinese

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B*1502 allele in Thai population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

HLA-B locus in Caucasian patients with carbamazepine hypersensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Carbamazepine, HLA-B*1502 and risk of Stevens-Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Balancing life-style and genomics research for disease prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

The persistence of the placebo response in antidepressant clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Alternatives to placebo-controlled trials in psychiatry. ECNP Consensus Meeting, September 26, 1996, Amsterdam. European College of Neuropsychopharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

National Depressive and Manic-Depressive Association consensus statement on the use of placebo in clinical trials of mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Clinical guidelines for psychiatrists for the use of pharmacogenetic testing for CYP450 2D6 and CYP450 2C19.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Public health. A case study of personalized medicine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Dopamine D3 receptor gene polymorphism and response to clozapine in schizophrenic Pakistani patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Analysis of a structural polymorphism in the 5-HT2A receptor and clinical response to clozapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Risk of Stevens-Johnson syndrome and toxic epider mal necrolysis during first weeks of antiepileptic therapy: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

Clinical Classification of Cases of Toxic Epidermal Necrolysis, Stevens-Johnson Syndrome, and Erythema Multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

The PDLIM5 gene and lithium prophylaxis: An association and gene expression analysis in Sardinian patients with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903508762

10.1517/14656560903508762

21 January 2018

Identifiers

DOI

1 reference

22 August 2017

1 reference

PubMed ID

20102306